Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal



Page Path
HOME > Diabetes Metab J > Volume 43(1); 2019 > Article
Special Editorial
DMJ, Better than Yesterday, More Brilliant Tomorrow
Kyu Chang Won, Editor-in-Chieforcid
Diabetes & Metabolism Journal 2019;43(1):1-2.
Published online: December 17, 2018
  • 54 Download
  • 1 Web of Science
  • 2 Crossref
  • 1 Scopus

Division of Endocrinology & Metabolism, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.

Corresponding author: Kyu Chang Won. Division of Endocrinology & Metabolism, Department of Internal Medicine, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea.

Copyright © 2019 Korean Diabetes Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Today is always better than yesterday. The Diabetes & Metabolism Journal (DMJ) is keeping up with this motto. As you know, DMJ is the cornerstone for diabetes research in 50 years of Korean Diabetes Association (KDA) history [1]. KDA has published ‘The Journal of Korean Diabetes Association’ in 1972 which is the first version of the official journal. DMJ has been renewed to a new version in 2011 and it is published bimonthly until now. The DMJ was indexed in the Science Citation Index Expanded (SCIE) in 2017. Apparently, this is totally attributed to your thankful accompany of DMJ. Nowadays, we feel the pressure of increasing amounts of new knowledge. Moreover, we realize that the increased clinical demands have led to a trend of narrowing interests in the general field of diabetology. In order to improve DMJ, we have some assignments to complete; to concern about Impact Factor (IF) of DMJ, to index DMJ in MEDLINE, and determine the policy of the article processing charge etc.
2017 DMJ's IF is 3.710. The matter of IF is always controversial. The inevitable truth is that IF has been used by promotion committees and by study sections as convenient value judgments of the worth of academic faculty and their research. DMJ wants to be supportive to our members' journey of going up the academic ladder. We want to be regarded as the first-choice journal for their best research given our quality and scope. Consequently, we have set a goal to increase our quality but not IFs. We are doing this by our acceptance rate about less than 30%. It will ensure that the general quality of our manuscripts will grow excellently, which means they will be more likely to be cited. It will also diminish the number of articles we publish, which will decrease the bulk of the Journal. This will inevitable increase our IF given this calculation is derived by dividing the number of times our articles are cited by the number of articles published. However, through improving IF, we should wisely sort out the way to increase the number of articles published.
Yet, it is time to apply to MEDLINE because MEDLINE journals have some merits as follows: first, it acquires the brand to be acknowledged by the reviewers of the United States National Library of Medicine Literature Selection Technical Review Committee (LSTRC); second, the Medical Subject heading terms can be added to the abstract in PubMed which enables more specific search results; next, it is automatically added in Scopus databases as MEDLINE-sourced title [2]. Although the third merit is not necessary for the journal, the editors should do their best to add the journal in MEDLINE. We made a new guideline for the preparation of the MEDLINE entry. Interns of the entry, we were particularly concentrated in the ethical issue.
One more thing is that we have made some policy changes. Applied on since January 1, 2019, an article processing charge of $500 will be applicable for articles accepted for publication in the DMJ. We appreciate your cooperation that this is also an inevitable policy to improve the quality of DMJ.
The old has gone, the new has come! DMJ is a new journey every day that we all make together. DMJ will be much better than yesterday and more brilliant in the future.

CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.

  • 1. Won JC, Rhee EJ, Yoo HJ. Fifty years of compassionate care and harmonious collaboration of the Korean Diabetes Association: The 50th anniversary of Korean Diabetes Association. Diabetes Metab J 2018;42:475-479. ArticlePubMedPMCPDF
  • 2. Huh S. Is Diabetes & Metabolism Journal eligible to be indexed in MEDLINE? Diabetes Metab J 2018;42:472-474. ArticlePubMedPMCPDF

Figure & Data



    Citations to this article as recorded by  
    • Effects of selenium on coronary artery disease, type 2 diabetes and their risk factors: a Mendelian randomization study
      Abigail A. Rath, H. Simon Lam, C. Mary Schooling
      European Journal of Clinical Nutrition.2021; 75(11): 1668.     CrossRef
    • Diabetes and Metabolism Journal in 2020: Good to Great
      In-Kyung Jeong
      Diabetes & Metabolism Journal.2020; 44(1): 1.     CrossRef

    • PubReader PubReader
    • Cite this Article
      Cite this Article
      export Copy Download
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      • Citation for the content below
      DMJ, Better than Yesterday, More Brilliant Tomorrow
      Diabetes Metab J. 2019;43(1):1-2.   Published online December 17, 2018
    • XML DownloadXML Download
    Won KC. DMJ, Better than Yesterday, More Brilliant Tomorrow. Diabetes Metab J. 2019;43(1):1-2.

    Diabetes Metab J : Diabetes & Metabolism Journal
    Close layer